Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Bullinger

Showing results (31-40 of 385) with videos related to

Pageof 39
Sort By:
Nucleic Acids Research|May 19, 2025
BEscreen: a versatile toolkit to design base editing librariesPhilipp G Schneider, Shuang Liu, Lars Bullinger, et al.
British Journal of Haematology|December 22, 2017
Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AMLMalgorzata Zajac, Joanna Zaleska, Anna Dolnik, et al.
Bioinformatics (Oxford, England)|June 29, 2017
Partitioned learning of deep Boltzmann machines for SNP dataMoritz Hess, Stefan Lenz, Tamara J Blätte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cellsJochen Greiner, Lars Bullinger, Barbara-ann Guinn, et al.
Hemasphere|October 15, 2025
Feasibility and acceptability of an online psychological group intervention for allogeneic hematopoietic stem cell transplantation inpatientsKarl Haller, Asita Behzadi, Johannes C Ehrenthal, et al.
Cancers|April 12, 2022
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New AgentsAdriane Halik, Christopher Maximilian Arends, Lars Bullinger, et al.
Oncology Research and Treatment|May 19, 2017
Novel Treatment Options in Head and Neck CancerPatrick J Schuler, Simon Laban, Johannes Doescher, et al.
Case Reports in Hematology|January 9, 2023
Relapse of <i>NPM1</i>-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell TransplantationJan Braune, Kathrin Rieger, Olga Blau, et al.
British Journal of Haematology|May 30, 2026
A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity-ECOG-Age criteriaDaniel Weidl, Myrto Boukovala, Doris Glaser, et al.
BMC Bioinformatics|September 1, 2016
Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary informationStefanie Hieke, Axel Benner, Richard F Schlenl, et al.
Pageof 39

Showing results (31-40 of 385) with videos related to

Sort By:
Pageof 39
Nucleic Acids Research|May 19, 2025
BEscreen: a versatile toolkit to design base editing librariesPhilipp G Schneider, Shuang Liu, Lars Bullinger, et al.
British Journal of Haematology|December 22, 2017
Expression of CD274 (PD-L1) is associated with unfavourable recurrent mutations in AMLMalgorzata Zajac, Joanna Zaleska, Anna Dolnik, et al.
Bioinformatics (Oxford, England)|June 29, 2017
Partitioned learning of deep Boltzmann machines for SNP dataMoritz Hess, Stefan Lenz, Tamara J Blätte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2008
Leukemia-associated antigens are critical for the proliferation of acute myeloid leukemia cellsJochen Greiner, Lars Bullinger, Barbara-ann Guinn, et al.
Hemasphere|October 15, 2025
Feasibility and acceptability of an online psychological group intervention for allogeneic hematopoietic stem cell transplantation inpatientsKarl Haller, Asita Behzadi, Johannes C Ehrenthal, et al.
Cancers|April 12, 2022
Refining AML Treatment: The Role of Genetics in Response and Resistance Evaluation to New AgentsAdriane Halik, Christopher Maximilian Arends, Lars Bullinger, et al.
Oncology Research and Treatment|May 19, 2017
Novel Treatment Options in Head and Neck CancerPatrick J Schuler, Simon Laban, Johannes Doescher, et al.
Case Reports in Hematology|January 9, 2023
Relapse of <i>NPM1</i>-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell TransplantationJan Braune, Kathrin Rieger, Olga Blau, et al.
British Journal of Haematology|May 30, 2026
A proposed refined definition of acute myeloid leukaemia patients ineligible for intensive therapy: The Integrated Comorbidity-ECOG-Age criteriaDaniel Weidl, Myrto Boukovala, Doris Glaser, et al.
BMC Bioinformatics|September 1, 2016
Integrating multiple molecular sources into a clinical risk prediction signature by extracting complementary informationStefanie Hieke, Axel Benner, Richard F Schlenl, et al.
Pageof 39